Cocaine hydrolase (Teva)

N/A

Report date: 2022/11/25 17:43:47

Base Information

Drug NameCocaine hydrolase (Teva)
Drug Alias Name可卡因水解酶 - 梯瓦Recombinant human serum albumin mutated butyrylcholinesteraseAlbu-BChEAlbu-CocHTV-1380 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionButyrylcholinesterase replacements
TargetsButyrylcholinesterase
Therapy Area/IndicationsCocaine-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCogenesys
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeva Branded Pharmaceutical Products R&D Inc
Active IndicationsN/A
Inactive IndicationsCocaine-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A